Hui Liu - 04 Apr 2022 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
04 Apr 2022
Net transactions value
$0
Form type
4
Filing time
06 Apr 2022, 19:59:33 UTC
Previous filing
02 Feb 2022
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +26,880 $0.000000 26,880 04 Apr 2022 Common Stock 26,880 $8.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on April 4, 2023.